Century Therapeutics (IPSC) Q4 2024 Earnings Report

295 Followers

IPSC Q4 2024 EPS Results

Actual EPS-$0.41

Consensus EPS-$0.41

Beat/MissMet expectations

One Year Ago EPS-$0.66

Actual Revenue$4.17M

Expected Revenue$784.00K

Beat/MissBeat by +$3.39M

YoY Revenue Growth+1457.09%

QuarterQ4 2024

Date03/19/2025

TimeAfter Close

Conference CallWednesday, March 19, 2025

IPSC Upcoming Earnings

Century Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-0.12 / -	-0.4	―
Aug 12, 2026	2026 (Q2)	-0.11 / -0.17	-0.38	55.26% (+0.21)
May 13, 2026	2026 (Q1)	-0.16 / -0.11	0.89	-112.36% (-1.00)
Mar 12, 2026	2025 (Q4)	-0.29 / -0.25	-0.41	39.02% (+0.16)
Nov 13, 2025	2025 (Q3)	-0.34 / -0.40	-0.37	-8.11% (-0.03)
Aug 14, 2025	2025 (Q2)	-0.38 / -0.38	-0.38	0.00% (0.00)
May 15, 2025	2025 (Q1)	>-0.01 / 0.89	-0.45	297.78% (+1.34)
Mar 19, 2025	2024 (Q4)	-0.41 / -0.41	-0.66	37.88% (+0.25)
Nov 05, 2024	2024 (Q3)	-0.45 / -0.37	-0.55	32.73% (+0.18)
Aug 08, 2024	2024 (Q2)	-0.46 / -0.38	-0.56	32.14% (+0.18)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed